Andrew N. Freedman
Division of Cancer Control and Population Sciences
National Cancer Institute
National Institutes of Health
Bethesda
USA
Name/email consistency: high
- Colorectal cancer risk prediction tool for white men and women without known susceptibility. Freedman, A.N., Slattery, M.L., Ballard-Barbash, R., Willis, G., Cann, B.J., Pee, D., Gail, M.H., Pfeiffer, R.M. J. Clin. Oncol. (2009)
- Cancer risk prediction models: a workshop on development, evaluation, and application. Freedman, A.N., Seminara, D., Gail, M.H., Hartge, P., Colditz, G.A., Ballard-Barbash, R., Pfeiffer, R.M. J. Natl. Cancer Inst. (2005)
- Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. Freedman, A.N., Graubard, B.I., Rao, S.R., McCaskill-Stevens, W., Ballard-Barbash, R., Gail, M.H. J. Natl. Cancer Inst. (2003)
- US physicians' attitudes toward genetic testing for cancer susceptibility. Freedman, A.N., Wideroff, L., Olson, L., Davis, W., Klabunde, C., Srinath, K.P., Reeve, B.B., Croyle, R.T., Ballard-Barbash, R. Am. J. Med. Genet. A (2003)
The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.








